Received a "Study May Proceed” letter from the U.S. Food and Drug Administration (FDA ... 3 trial for the first-line ...

Journey Medical Corporation (Nasdaq: DERM) ("Journey Medical” or "the Company”, "we”, or "our”), a commercial-stage ...

Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

6. Cell therapy for melanoma The U.S. Food and Drug Administration (FDA) approved the first cellular therapy for aggressive ...

GNSC-001 is an investigational, adeno-associated virus gene therapy expressing an optimized form of IL-1Ra. The Food and Drug Administration (FDA) has granted Fast Track designation to GNSC-001 for ...

In the wake of the biggest American political comeback in more than 100 years, stakeholders in the health industry are asking themselves: What ...

At the first sign of a runny nose many people dash out to buy a cold and flu remedy - but soon that might become harder to do ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.

Camphor, a traditional ingredient in South Asian desserts, offers a unique cooling flavor and cultural significance. While ...

Research Triangle Park, North Carolina Saturday, November 9, 2024, 13:00 Hrs [IST] ...